Skip to main content
Retour
Watch Compare

Scienture Holdings, Inc.

Qualité des données : 100%
SCNX
Nasdaq Manufacturing Chemicals
0,33 €
▼ 0,01 € (-2,35%)
Cap. Boursière: 14,21 M
Prix
0,35 €
Cap. Boursière
14,21 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue declined -54,29% annually over 5 years
Earnings declined -557,90% over the past year
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -13,39 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 270,16%
Capital efficient — spends only 2,78% of revenue on capex

Croissance

Revenue Growth (5Y)
-54,29%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)215,87%
Earnings (1Y)-557,90%
FCF Growth (3Y)N/A

Qualité

Return on Equity
-51,72%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC-34,67%
Net Margin-9618,03%
Op. Margin-9867,92%

Sécurité

Debt / Equity
0,02
En dessous de la moyenne du secteur (0,31)
Current Ratio0,19
Interest Coverage-10,43

Valorisation

PE (TTM)
-0,34
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio0,17
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,3 -1,5
P/B 0,2 1,6
ROE % -51,7 -53,3
Net Margin % -9618,0 -41,5
Rev Growth 5Y % -54,3 1,8
D/E 0,0 0,3

Objectif de Cours des Analystes

1 analyste
Strong Buy
Actuel
0,33 €
+350.5%
Objectif
1,50 €
1,50 €
1,50 €
1,50 €
Prévisions
P/E Prévisionnel -1,59
BPA Prévisionnel -0,21 €
CA Est. 17,22 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,21 €
-0,21 € – -0,21 €
 17,22 M 1
FY2026 -0,72 €
-0,72 € – -0,72 €
 5,07 M 1

Surprises de Résultats

Dernier 1 trimestre
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,28 € -0,13 € +54,7%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 215,87% Revenue Growth (3Y) -77,16%
Earnings Growth (1Y) -557,90% Earnings Growth (3Y) N/A
Revenue Growth (5Y) -54,29% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 431 609,0 Net Income (TTM) -41,51 M
ROE -51,72% ROA -39,70%
Gross Margin 76,80% Operating Margin -9867,92%
Net Margin -9618,03% Free Cash Flow (TTM) -13,39 M
ROIC -34,67% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,02 Current Ratio 0,19
Interest Coverage -10,43 Asset Turnover 0,00
Working Capital -5,93 M Tangible Book Value -15,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,34 Forward P/E N/A
P/B Ratio 0,17 P/S Ratio 32,92
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -94,25%
Market Cap 14,21 M Enterprise Value 16,21 M
Per Share
EPS (Diluted TTM) -2,70 Revenue / Share 0,01
FCF / Share -0,33 OCF / Share -0,33
EPS CAGR (1Y) -208,87% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2,78% FCF Conversion 32,26%
SBC-Adj. FCF -15,21 M Growth Momentum 270,16

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 431 609,0 136 643,0 8,27 M 11,45 M 17,12 M
Net Income -41,51 M 9,07 M -17,84 M -3,47 M -2,54 M
EPS (Diluted) -2,70 2,48 -7,49 -0,41 —
Gross Profit 331 482,0 6 005,0 2,60 M 5,45 M 5,71 M
Operating Income -42,59 M -14,70 M -7,26 M -4,42 M -2,51 M
EBITDA — — — — —
R&D Expenses 1,96 M 2,24 M — — —
SG&A Expenses — — — — —
D&A 491 781,0 — — — —
Interest Expense 4,08 M 1,34 M 1,20 M 336 206,0 29 389,0
Income Tax -1,99 M -534 396,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2023 FY2024 FY2022 FY2020
Total Assets 84,18 M 12,53 M 104,85 M 3,71 M 9,79 M
Total Liabilities 14,06 M 11,99 M 25,78 M 3,37 M 1,11 M
Shareholders' Equity 70,12 M 542 353,0 79,07 M 763 136,0 8,68 M
Total Debt 2,90 M — 2,90 M — —
Cash & Equivalents 6,66 M 151 908,0 — 1,13 M 5,92 M
Current Assets 7,92 M 2,75 M 6,31 M 2,09 M 9,22 M
Current Liabilities 2,74 M 11,56 M 7,91 M 2,15 M 842 238,0